Trade Secrets Tech Summit: FyndTravel
This season, Trade Secrets is hosting the Trade Secrets Tech Summit. Every Monday, co-hosts Emma Weissmann and Jamie Biesiada will feature a different travel technology company that works with travel advisors. A representative from the featured company will begin with a 5-minute elevator pitch to tell advisors about their product, followed by a 15-minute Q-and-A with the hosts.
This week's featured company is FyndTravel, represented by founder and owner Lisa Watson.
Trade Secrets is using Host Agency Reviews' list of technology providers as a basis for this season. If a technology company doesn't have a profile, advisors are encouraged to send a link to the hosts to be added to the list. This episode was sponsored by National Geographic-Lindblad Expeditions.
Further resources
FyndTravel on the web
Email Lisa Watson
Facebook group Travel Industry Events Guide
Get in touch!
Email us: tradesecrets@travelweekly.com
Theme song
Sock Hop by Kevin MacLeod
License
See omnystudio.com/listener for privacy information.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
Jackson Local Schools to seek levy renewal on the Nov. 4 ballot
JACKSON TWP. – Jackson Local Schools voters will see a renewal levy on the Nov. 4 ballot. The Board of Education approved the tax request at a special meeting on Aug. 4. Voters will be asked to renew a five-year substitute levy first approved by voters in 2011 at a rate of 6.5 mills. It was renewed in 2011 and 2016. This time around, voters will consider a 3.9-mill levy that will generate $9,290,700 each year. Existing taxpayers will see no additional taxes with the levy's approval, school officials said. The substitute levy will generate additional funds from new any new construction in the district. If approved, the tax will cost a homeowner $119 per year for every $100,000 in property tax valuation. This article originally appeared on The Independent: Jackson Schools OKs renewal levy on Nov. 4 ballot; no new taxes Solve the daily Crossword
Yahoo
12 minutes ago
- Yahoo
Gas versus renewables: how will the power demand of data centres be met?
Texas is renowned for its ranching industry, but this oldest of American vocations is fast becoming entwined with icons of modern life: solar and wind farms. Among the cattle, Texas is also home to more than 15,300 wind turbines across 239 projects and 197 utility-scale solar farms. 'Solar and wind energy now frequently provide more than 45% of the state's electricity needs,' says Dennis Wamsted of the Institute for Energy Economics and Financial Analysis. With such strong credentials in renewables, it is little wonder that proposals to build more than 100 new gas-fired power plants were met with furore among some. According to non-profit environmental group Environmental Integrity Project (EIP), as of April 2025, plans were afoot to build 108 new facilities and expand 17 others, adding as much as 58GW; there were also proposals, without specific detail, for five other projects. In a June report, the EIP said many of the proposals included requests to access the Texas Energy Fund, which meant using state taxpayer dollars, adding further fuel to the fire. The group identified proposals such as the 930MW three gas‐turbine project near Corpus Christi; the 900MW two gas-turbine project west of Houston; and another 900MW facility to the south-west of the city. Wamsted notes that how many of the proposals EIP identified will actually be built is left unanswered and believes Texas will continue to lead US renewables. However, 'Texas is also the leading market for gas-based thermal power', caveats Pavan Vyakaranam, energy analyst at Power Technology's parent company GlobalData. According to GlobalData, Texas was home to 81.53GW of gas power capacity in 2024, far beyond runner-up Florida's 54.96GW. It is becoming increasingly likely that the state's clean energy push may not go hand in hand with equal efforts to reduce thermal power as the energy transition requires – but why is Texas, alongside other US states and industrialised countries, looking at gas again? Tech needs gas Data centres are increasingly in demand as AI and automation markets boom. In the US, data centre investments nearly quadrupled between 2019 and 2024, according to International Energy Agency (IEA). Wamsted says it is clear that in Texas, data centre buildout is a strong driving force behind the projected increase in power demand placed on the Electric Reliability Council of Texas (ERCOT). This is not just a problem for Texas. IEA data shows that globally, data centre electricity consumption is expected to more than double to around 945 terawatt-hours by 2030. The Trump administration has pushed for data centre and energy co-expansion across US states through favourable conditions such as tax incentives. The latest state to signal its intent to bank on this opportunity was Pennsylvania, which secured investment in excess of $90bn from technology, energy and finance companies to become an AI hub backed by state and federal economic incentives. Although many of the rumoured projects for this hub include clean energy, some are said to contain plans for new natural gas facilities, raising questions of which energy source is best suited to meet date centres' needs. In the US at least, with the Trump administration's preference for hydrocarbons, gas power holds a significant advantage, says Vyakaranam. 'In order to meet such a huge increase in demand [from data centres], there is a need for large capacity additions. With [Trump's] pro-fossil fuel policies in place, it is both more economical and, from clearances perspective, easier to roll out gas-based projects than others like renewables.' He also notes that gas power offers better grid stability with flexibility – able to be quickly started and stopped – and reliability – providing constant power generation to ensure continuous operations for data centres – in comparison to renewables. 'Renewable power, due to its intermittent nature, cannot be a sole solution [for data centres] without any backup power or storage.' However, Wamsted is dismissive of the notion that gas is absolutely needed, saying any rise in demand can be met reliably and economically by renewable sources in markets like Texas with significant renewable capacity. '[In Texas] the 24/7 power demand sought by data centres and other high load users can be supplied by the ERCOT system. Saying data centres require gas or nuclear since they are supposedly more reliable is misleading,' he argues. Do renewables have the power over gas? Wamsted notes that Texas' growing renewables capacity meets much of the state's needs even as demand on the ERCOT climbed by 31.3% between 2016 and 2024. 'Texas actually is a prime example of how quickly we can transition grids from fossil fuels to renewable energy, even without state support,' he says. In theory, Texas could prove it is possible to power the AI future with clean energy. Many Texas-based data centres are already trialling this. In 2024, Sabey Data Center Properties completed the construction of a Tier III two-storey 19,875m² facility in Austin, with a commitment to operate on 100% renewable energy. Similarly, Equinix built a Tier IV facility in Dallas to be entirely powered on renewables. As recently as April 2025, Soluna Holdings' said its 120MW South Texas data centre project, Project Hedy, will also be powered entirely by wind. There are others outside of the US, notes Vyakaranam. Malaysia's Bridge Data Centres is actively integrating 400MW of renewable energy into its operations, with a commitment to achieve carbon neutrality by 2040. The country's AirTrunk Operating is also constructing a data centre with the capacity to generate up to 30MW of renewable energy. Despite these noteworthy blueprints, however, it seems Malaysia will also go big on gas as it tries to reduce coal use, yet balance the economic benefit of a growing data centre industry with the power it needs. With projections that the country will see demand triple in the five years to 2027, it plans to add 6–8GW of gas-fired capacity by the beginning of the next decade, according to the CEO of state utility provider Tenaga Nasional Berhad, Megat Jalaluddin. While the country also has a goal of doubling its renewable capacity by 2030, overall, the transition to clean energy is more a long-term goal than one to meet the urgent demands of data centres. Meanwhile, Vyakaranam says the US renewables sector is facing major challenges under the current administration, with Texas being no exception. 'Trump's position is poised to result in a significant increase in the growth of gas-powered energy production and stagnation of the renewables market,' he says. This approach has its own difficulties. The US, Malaysia and others looking at a gas power boom face stiff competition for gas components – thus, heftier price tags. The substantial increase in the gas-based project pipeline has seen the lead time for gas turbines reach around 5–7 years, according to GlobalData, meaning equipment manufacturers have had to ramp up production as they contend with huge order backlogs. 'Power generation companies, in order to secure turbine supplies, are engaging in aggressive procurement strategies such as making order requests years in advance, diversifying their supplier network, and coming up with different project designs and configurations to avoid any grid reliability shortfalls,' Vyakaranam notes. These considerations threaten Texas' new gas turbine plans as they 'cannot be resolved quickly, if at all', warns Wamsted, adding that engineering, procurement and construction companies have 'limited capability to meet the rapid proposed buildout'. 'Both of these capacity problems are raising the cost of gas-fired generation, which could put a brake on planned additions,' he continues. 'New gas pipelines will be needed for many of the planned expansion efforts, which will take time and have significant capital costs.' Are Malaysia and Texas part of a bigger picture? Vyakaranam believes that renewables alone cannot yet power the world through its AI revolution – instead, gas power has to be part of the mix. 'Although there will be a continued push towards renewables and battery storage innovations, which will eventually help meet data centres' demand,' he says, 'gas and nuclear will have to do some of the heavy lifting in the meantime.' Wamsted takes a different view: 'I would say it is renewables that can quickly and affordably meet the US' rising electricity needs, not gas, which may be sold out through 2030, or nuclear, which is unlikely to add significant new capacity before 2035 at earliest.' He also cautions against relying on gas alone. 'All generation systems require maintenance and have unforced outages during the year […] Relying on one resource – or worse, one facility – would be highly risky,' he says. However, the same could be said about renewables, particularly given their reliance on weather conditions and without the support of energy storage. With data centres – and everything they enable – now part of our world, it seems energy transition hopes are destined to do battle with our thirst for technology. With strong support and opposition for both renewables and gas power to support the AI boom, the reality is likely somewhere in between. Therefore, perhaps Texas and Malaysia have got it right, in spite of the raised eyebrows their approaches elicit. With battery storage still lacking, new gas turbines backlogged and nuclear, at best, a long-term investment, the best way to meet the exponentially increasing demand from data centres may be for renewables and gas power to work together. Of course, even this peculiar collaboration is not enough. To ensure a reliable and sustainable AI future, power capacity additions – regardless of energy source – will need to be paired with efforts to upgrade ageing grids, expand energy storage and decentralise energy systems as a whole, while tailoring energy solutions for each data centre to its local surroundings. "Gas versus renewables: how will the power demand of data centres be met?" was originally created and published by Power Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12 minutes ago
- Yahoo
Organ Care Products Market Valuation Set to Surpass US$ 812.12 Million By 2033
Innovation now defines the organ care products market. Advanced perfusion and portable systems are actively expanding the donor organ pool, tackling immense waiting lists driven by chronic diseases and dramatically improving success rates for vital transplants. Chicago, Aug. 04, 2025 (GLOBE NEWSWIRE) -- The global organ care products market was valued at US$ 199.20 million in 2024 and is expected to reach US$ 812.12 million by 2033, growing at a CAGR of 16.90% during the forecast period 2025–2033. The current scenario in the organ care products market is one of explosive growth, fueled by the twin engines of unprecedented global demand and transformative technology. In 2024, the U.S. performed a record 48,149 transplants, yet this barely meets the need, as regions like Eurotransplant still have over 13,570 patients on waiting lists. This profound supply-demand imbalance is accelerating a fundamental shift away from traditional static cold storage towards advanced perfusion and assessment systems. These technologies are directly addressing the critical issue of organ non-utilization, aiming to convert a portion of the thousands of organs discarded annually into life-saving opportunities, thereby changing the entire calculus of transplantation. Request Sample Pages: This evolution is being aggressively capitalized upon by key industry players through strategic expansion and is buoyed by substantial investment. Recent developments, such as Paragonix's EU MDR certification for five devices in March 2025 and its rapid U.S. commercial expansion, highlight a fierce race to capture market share. The market's momentum is further underwritten by significant capital influx, from government initiatives like the $67 million allocated for U.S. transplant system modernization in FY2025 to targeted research funding from organizations like Enduring Hearts. The current scenario is therefore not just about growth, but about a well-funded, strategic push to commercialize innovation on a global scale. Key Findings in Organ Care Products Market Market Forecast (2033) US$ 812.12 million CAGR 16.90% Largest Region (2024) North America (56%) By Organ Type Kidney (28%) By Product Type Trolly (53%) Top Drivers Rising global incidence of chronic diseases fuels organ transplant demand. Technological advancements in organ preservation systems improve transplant success rates. Favorable reimbursement policies encourage organ transplant procedures, boosting market growth. Top Trends Emergence of normothermic machine perfusion for real-time organ function assessment. Development of smaller, portable organ preservation devices for easier transport. Focus on developing organ-specific preservation solutions for better patient outcomes. Top Challenges Complex ethical and logistical hurdles in organ procurement and allocation. Unprecedented Transplant Volumes Are Fueling Robust Market Expansion and Demand The foundational driver for the organ care products market is the sheer volume of surgical procedures, which continued its upward trajectory through 2024. In the United States alone, a record of over 48,000 organ transplants were performed. This milestone was confirmed with a final tally of 48,149 procedures for the year, marking the first time the nation has exceeded this figure. This represents an impressive average of 132 organ transplants performed each day in the U.S. throughout 2024. Critically, 2024 marked the 14th consecutive year of growth in the number of organs recovered for transplants in the U.S., signaling a sustained and reliable increase in the core activity that underpins the market. This trend is not isolated; globally, organ transplantation activities saw a notable increase in 2023, which has set a strong precedent for continued growth in 2024 and beyond. In Europe, the eight Eurotransplant countries allocated 7,150 organs from deceased donors in 2024, while in China, a remarkable 24,684 transplant surgeries were performed during the same year, showcasing the truly global nature of this expansion. The Critical Role of Organ Procurement in Shaping Market Dynamics The availability and procurement of donor organs represent the starting point for the entire transplantation value chain, directly influencing the organ care products market. In the United States, 55 dedicated organ procurement organizations (OPOs) were operational as of October 2024, forming the backbone of the recovery network. In 2024, these U.S. OPOs successfully recovered over 45,000 organs for transplant procedures. This was made possible by the 16,989 Americans who became deceased organ donors, a testament to growing awareness and consent. These efforts were supplemented by more than 7,000 living donors in the U.S. in 2024. An interesting demographic trend shows that nearly 8,200 of the deceased donors in the U.S. in 2024 were aged 55 and older, highlighting the expanding criteria for donation. In the United Kingdom, from April 2023 to March 2024, there were 1,510 deceased organ donors and 938 living organ donors. Across the Eurotransplant region, organs were sourced from 2,181 deceased donors in 2024. Meanwhile, China recorded 6,744 cases of organ donations in 2024, with the number of registered organ donors soaring to over 7.05 million by early 2025, indicating massive future potential. Organ-Specific Procedural Growth Creates Niche Opportunities Within the Market A deeper analysis of procedural data reveals that growth is not uniform across all organ types, creating distinct and lucrative opportunities within the organ care products market for specialized preservation technologies. In the United States during 2024, cardiac procedures were significant, with 4,572 heart transplants performed. Thoracic procedures were also prominent, as the number of lung transplants reached 3,340. Abdominal transplants, which constitute the largest segment, saw a total of 11,458 liver transplants and an impressive 27,759 kidney transplants performed in the U.S. in 2024. This high volume in renal transplantation underscores the demand for reliable kidney preservation solutions. Furthermore, specialized procedures are gaining traction; in the UK, for instance, 65 Donation after Circulatory Death (DCD) heart transplants took place in the 2023/24 period, a complex procedure that relies heavily on advanced preservation technology to ensure viability. Diverse Regional Landscapes Present Unique Challenges and Growth Avenues The global organ care products market is characterized by significant regional variations in infrastructure, regulatory frameworks, and donation patterns. China's market, for example, is notable for its scale; as of early 2025, there have been more than 58,000 cumulative organ donations to date. The country has also recorded over 63,000 body donations and 110,000 corneal donations as of 2025, pointing to a well-established and growing donation culture. In the UK, the data from 2023-2024 provides a detailed look at the procurement funnel, with 772 donors after brain death (DBD) and 738 donors after circulatory death (DCD). That year, there were 6,794 potential deceased organ donors identified in the UK, of whom 6,421 were formally referred as potential donors. From that pool, donation requests were made to families in 3,107 cases, ultimately resulting in 1,880 consented donors, illustrating the multi-step process where advanced care technology can play a role in boosting confidence and consent. Groundbreaking Product Innovation and Regulatory Wins Propel Market Leaders Forward Innovation is the lifeblood of the organ care products market, with regulatory approvals serving as key milestones that unlock new commercial opportunities. In October 2024, Paragonix Technologies achieved a major milestone with FDA 510(k) clearance for its KidneyVault portable renal perfusion system. This strategic clearance solidified Paragonix as the only company possessing U.S. regulatory clearances for advanced preservation devices for all five solid organs used in transplants. Earlier in the year, in June 2024, the company launched its PancreasPak, the world's first FDA-cleared preservation device for donor pancreases, with pre-orders beginning on June 27, 2024, and full commercial availability planned for September 1, 2024. In April 2024, Paragonix also announced the full U.S. commercial launch of its BAROguard Donor Lung Preservation System. During its limited market release, 5 of the top U.S. thoracic transplant centers had already deployed the BAROguard System. The momentum continued into 2025, when Paragonix received EU MDR approval for five of its organ preservation devices in March. These specific product approvals stood out in a year where the FDA approved a total of just 21 medical devices overall in 2024. Strong Financial Performance and Strategic Investments Signal a Healthy Marketplace The financial health and strategic initiatives of key industry players in the organ care products market provide compelling evidence of a vibrant and growing market. XVIVO Perfusion reported strong results for 2024, with net sales amounting to SEK 822.4 million for the full year. The fourth quarter of 2024 was particularly robust, with net sales reaching SEK 227.6 million. The company's profitability was also solid, with an operating income (EBIT) for Q4 2024 of SEK 15.5 million and an operating income before depreciation and amortization (EBITDA) of SEK 51.9 million. Strong operational execution led to a cash flow from operating activities of SEK 62.1 million in Q4 2024, and the company posted a net profit for the full year 2024 of SEK 172.2 million. On the utilization front, Paragonix preservation devices have been used in over 10,000 transplant cases globally as of March 2025, demonstrating deep market penetration. Specifically, the Paragonix SherpaPak and LUNGguard systems are utilized at over 150 transplant centers globally, including over 40 transplant centers in the EU, highlighting the company's expanding international footprint. Modernization Initiatives and Research Funding Pave the Way for Future Growth Substantial government and institutional investments in research and system modernization are creating a fertile ground for the future growth of the organ care products market. The U.S. Senate Appropriations Committee has included a significant $67 million in funding for the Organ Procurement and Transplantation Network (OPTN) Modernization Initiative for fiscal year 2025. This represents a $13 million increase over FY 2024 levels. The FY24 funding package had already included an additional $23 Million for the HRSA OPTN Modernization Initiative, bringing the total for that year to $52 Million. In 2024, the Mid-America Transplant Foundation's Clinical Innovation Fund began offering awards of up to $150,000 per year for three years to spur new research. The American Society of Transplantation (AST) is furthering this by offering a research grant of $75,000 for one year, with a term starting January 1, 2025. The International Society for Heart & Lung Transplantation is offering a grant of up to $75,000 for research into DCD heart transplantation, with recipients to be announced in January 2025, and a second grant of up to $37,500 for acellular Ex Vivo Lung Perfusion (EVLP) research. In 2024, the Scandiatransplant Research grant also supported two projects with 100,630 DKK and 260,000 DKK, respectively. Need a Customized Version? Request It Now: Addressing Organ Utilization and Waiting Lists Remains a Core Market Imperative The persistent challenges of organ non-utilization and extensive patient waiting lists serve as powerful catalysts for the organ care products market, driving the need for technologies that can preserve, assess, and improve marginal organs. In 2024, a concerning 9,275 recovered kidneys in the U.S. were ultimately not used for transplant, continuing a trend that highlights a critical gap between recovery and utilization. To combat this, OPOs have hosted eleven Transplant Growth Collaborations over the past year to share successful practices. Advanced perfusion is emerging as a key solution; a 2024 study of 803 transplantations, of which 174 received Normothermic Machine Perfusion (NMP), showed NMP was associated with a reduced need for early relaparotomy in liver transplants. Another 2024 study involving 118 NMP-treated livers matched with 236 preserved with static cold storage, and a cohort matching 37 NMP-DCD livers with 74 using static cold storage, are providing crucial data on efficacy. Global Organ Care Products Market Major Players: Bridge to Life Ltd. TransMedics Inc. Organ Recovery system XVIVO Preservation Solution Inc. Paragonix technologies and IGL OrganOx Limited Other Prominent Players Key Market Segmentation: By Organ Type Kidney Liver Heart Lungs Others By Product Type Trolly Portable By Region North America Europe Asia Pacific Middle East Africa South America Request a Personalized Report Walkthrough with Our Research Team: About Astute Analytica Astute Analytica is a global market research and advisory firm providing data-driven insights across industries such as technology, healthcare, chemicals, semiconductors, FMCG, and more. We publish multiple reports daily, equipping businesses with the intelligence they need to navigate market trends, emerging opportunities, competitive landscapes, and technological advancements. With a team of experienced business analysts, economists, and industry experts, we deliver accurate, in-depth, and actionable research tailored to meet the strategic needs of our clients. At Astute Analytica, our clients come first, and we are committed to delivering cost-effective, high-value research solutions that drive success in an evolving marketplace. Contact Us:Astute AnalyticaPhone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)For Sales Enquiries: sales@ Follow us on: LinkedIn | Twitter | YouTube CONTACT: Contact Us: Astute Analytica Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World) For Sales Enquiries: sales@ Website: in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
